Webinar
Moving Science Forward in Alzheimer's Disease Clinical Trials
calendar

April 28, 2022

Calendar
clock

11:00am - 12:00pm

GMT-04:00

Register

View all IQVIA events

Alzheimer's disease affects more than 20 million people worldwide. More people will be impacted as the cohort of adults aged 65 and older rises and if disease modifying therapies are not fully approved. Clinical trials for Alzheimer's disease are scientifically and operationally challenging. Sponsors need innovative solutions to drive new therapies to market.

In this webinar, IQVIA experts will share how to harness data, technology, and advanced analytics to inclusively recruit the right patients in the right places at the right time into Alzheimer's disease clinical trials. Learn how to:

  • Operationalize the trial designs optimized to bring Alzheimer's disease therapies forward
  • Generate appropriately representative patient enrollment into your Alzheimer's disease clinical trials
  • Investigate the impact of heterogeneity in your patient population

Related solutions

Contact Us